Detalhe da pesquisa
1.
Inter- and Intra-individual Variation, and Limited Prognostic Utility, of Serum Alkaline Phosphatase in a Trial of Patients With Primary Sclerosing Cholangitis.
Clin Gastroenterol Hepatol;
19(6): 1248-1257, 2021 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32707342
2.
Twelve weeks of ledipasvir/sofosbuvir all-oral regimen for patients with chronic hepatitis C genotype 2 infection: Integrated analysis of three clinical trials.
Hepatol Res;
50(10): 1109-1117, 2020 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32614468
3.
Ten-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infection.
Liver Int;
39(10): 1868-1875, 2019 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31136052
4.
Correction to: Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis.
Dig Dis Sci;
64(1): 285-286, 2019 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30324553
5.
Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis.
Dig Dis Sci;
63(12): 3487-3497, 2018 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30136045
6.
Efficacy and safety of filgotinib as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a post-hoc analysis of the phase 2b/3 SELECTION trial.
Intest Res;
21(1): 110-125, 2023 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35263963
7.
Safety and efficacy of stopping tenofovir disoproxil fumarate in patients with chronic hepatitis B following at least 8 years of therapy: a prespecified follow-up analysis of two randomised trials.
Lancet Gastroenterol Hepatol;
4(4): 296-304, 2019 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30795958
8.
Teriparatide reduces the fracture risk associated with increasing number and severity of osteoporotic fractures.
J Clin Endocrinol Metab;
90(3): 1583-7, 2005 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15613428
9.
Prognostic utility of a semiquantitative spinal deformity index.
Bone;
37(2): 175-9, 2005 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15922683
10.
Reduction in vertebral fracture risk in teriparatide-treated postmenopausal women as assessed by spinal deformity index.
Bone;
37(2): 170-4, 2005 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15961357
11.
Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate.
J Bone Miner Res;
19(5): 745-51, 2004 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15068497
12.
Relationship between changes in biochemical markers of bone turnover and BMD to predict vertebral fracture risk.
J Bone Miner Res;
19(3): 394-401, 2004 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15040827
13.
Efficacy and safety of raloxifene 60 milligrams/day in postmenopausal Asian women.
J Clin Endocrinol Metab;
88(7): 3130-6, 2003 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12843154
14.
Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years.
Menopause;
10(4): 337-44, 2003.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12851517
15.
Raloxifene prevents the growth of uterine leiomyomas in premenopausal women.
Fertil Steril;
81(1): 132-6, 2004 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-14711556
16.
How conservative is Fisher's exact test? A quantitative evaluation of the two-sample comparative binomial trial.
Stat Med;
27(18): 3598-611, 2008 Aug 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18338319
17.
Anti-vertebral fracture efficacy of raloxifene: a meta-analysis.
Osteoporos Int;
17(2): 313-6, 2006 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16217588
18.
Effects of raloxifene, hormone replacement therapy, and placebo on bone turnover in postmenopausal women.
Osteoporos Int;
14(10): 814-22, 2003 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-14610642